UK projects growth in drug spending through 2014

04/15/2013 | PharmaTimes (U.K.)

Annual spending in the U.K. will increase by 0.5% to 1.8% on branded drugs and 10% to 11% on generics through 2015, according to the Office of Health Economics. Analysts used a new "bottom-up" method to base the forecast on input from industry executives regarding new branded products as well as generic and biosimilar drugs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX